Mississauga, ON -- (SBWire) -- 03/27/2017 --AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "OncBioMune Sales Top Forecast, Shares Run at Opening Bell."

Companies mentioned in this article include OncBioMune Pharmaceuticals (OTCQB:OBMP).

Article Excerpt:

It's rare to see a young biotech generating revenue as it brings drug candidates down the clinical pathway, but that's exactly what OncBioMune Pharmaceuticals (OTCQB:OBMP) is doing. Earlier this month, the company acquired Mexico City-based Vitel Laboratorios, giving it two drugs commercialized in the Mexican markets and a pipeline of over 20 more products to add to its existing portfolio that is led by OncBioMune's flagship prostate cancer vaccine ProscaVax. Leveraging promising data from an ongoing Phase 1 study, ProscaVax is set to commence Phase 2 studies in the U.S. and Mexico in the near-term.

Shares of OBMP are hopping this morning on increased volume on news that sales of Bekunis and Cirkused, over-the-counter medications for constipation and stress, respectively, are outstripping expectations. Only launched last September, the products have combined sales of about $330,000 in their fist six months on the market. That's 164% higher than the $125,000 OncBioMune expected during the first months following launch.

The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/733/oncbiomune-sales-top-forecast-shares-run-at-opening-bell.htm

About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.

AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.

Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999.

Investors can receive their free newsletter subscription by clicking here:
http://www.allpennystocks.com/aps_common/newsletter_free.asp

Contact:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: 905-361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com

Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp